RS
IONS icon

R Squared’s Ionis Pharmaceuticals IONS Stock Holding History

R Squared’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$327K Buy
+4,359
New +$344K 0.18% 180

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

R Squared's IONS Position: Q1 2026 in Review

R Squared opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 4,359 shares worth $327K. The stake represents 0.18% of the portfolio and ranks #180 among its holdings.

493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • R Squared held 4,359 shares of Ionis Pharmaceuticals worth $327K as of Q1 2026.
  • Ionis Pharmaceuticals was a new R Squared position in Q1 2026.
  • Ionis Pharmaceuticals made up 0.18% of R Squared's portfolio in Q1 2026, its #180 holding.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.